PendiumPendium

Step 1 of 9

AI agents treat Cost Plus Drugs as the gold standard for pharmacy transparency in an industry known for secrets.

You have a strong lead in reputation, but competitors with deeper affiliate networks and insurance integrations still win on many general savings prompts.

Mark Cuban Cost Plus Drug Company's baseline score
78/100
Good

Cost Plus Drugs has built a high-trust AI profile by sticking to a simple, repeatable pricing formula that AI agents find easy to explain. While visibility is excellent for brand-direct queries, there is an opening to own more condition-specific discovery prompts where competitors still dominate the conversation.

What we see
  • The brand has exceptional visibility in ChatGPT and Claude due to massive editorial coverage since its 2022 launch.
  • Gemini and AI Overviews frequently surface the brand in 'best online pharmacy' and 'prescription savings' queries, often alongside GoodRx.
  • AI agents rely on the founder's name as a shortcut for authority, which boosts the brand's knowledge score significantly.
  • The specific 'Cost + 15%' math is a 'sticky' fact that AI agents repeat consistently across all platforms.
  • There is a visibility gap in condition-specific searches where AI assistants still favor traditional health portals like WebMD or Mayo Clinic for medication advice.
Business goals Mark Cuban Cost Plus Drug Company is likely trying to hit
  • Expand the catalog of generic medications for chronic conditions
  • Increase direct integrations with employer-sponsored health plans
  • Convert GoodRx coupon users into direct pharmacy customers
  • Drive awareness of the transparent cost-plus pricing model